OncoMed Pharmaceuticals Inc Net Income
OncoMed Pharmaceuticals Inc reported Net Income of -$4.67 million for the 3-month period ending 2018-12-31, per its 10-K filed 2019-03-07.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2019-03-07
- OncoMed Pharmaceuticals Inc net income (loss) attributable to parent for the quarter ending 2018-12-31 was -$4.67M, a 149.31% decline year-over-year.
- OncoMed Pharmaceuticals Inc net income (loss) attributable to parent for the quarter ending 2018-09-30 was $6.12M.
- OncoMed Pharmaceuticals Inc net income (loss) attributable to parent for the quarter ending 2018-06-30 was -$3.98M.
- OncoMed Pharmaceuticals Inc net income (loss) attributable to parent for the quarter ending 2018-03-31 was -$5.57M.
- OncoMed Pharmaceuticals Inc net income (loss) attributable to parent for fiscal 2018 was -$8.10M.
- OncoMed Pharmaceuticals Inc net income (loss) attributable to parent for fiscal 2017 was -$39.06M.
- OncoMed Pharmaceuticals Inc net income (loss) attributable to parent for fiscal 2016 was -$103.10M.
- OncoMed Pharmaceuticals Inc net income (loss) attributable to parent for fiscal 2015 was -$85.41M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|
| 2018-12-31 | -$4.67M 10-K · filed 2019-03-07 | $1.45M derived: sum of 2 quarters · filed 2019-03-07 | -$2.53M derived: sum of 3 quarters · filed 2019-03-07 | -$8.10M 10-K · filed 2019-03-07 |
| 2018-09-30 | $6.12M 10-K · filed 2019-03-07 | $2.14M derived: sum of 2 quarters · filed 2019-03-07 | -$3.44M 10-Q · filed 2018-11-01 | $6.03M derived: sum of 4 quarters · filed 2019-03-07 |
| 2018-06-30 | -$3.98M 10-K · filed 2019-03-07 | -$9.55M 10-Q · filed 2018-08-02 | -$87.00K derived: sum of 3 quarters · filed 2019-03-07 | -$10.78M derived: sum of 4 quarters · filed 2019-03-07 |
| 2018-03-31 | -$5.57M 10-K · filed 2019-03-07 | $3.89M derived: sum of 2 quarters · filed 2019-03-07 | -$6.80M derived: sum of 3 quarters · filed 2019-03-07 | -$22.03M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-12-31 | $9.46M 10-K · filed 2019-03-07 | -$1.23M derived: sum of 2 quarters · filed 2019-03-07 | -$16.45M derived: sum of 3 quarters · filed 2019-03-07 | -$39.06M 10-K · filed 2019-03-07 |
| 2017-09-30 | -$10.69M 10-K · filed 2019-03-07 | -$25.92M derived: sum of 2 quarters · filed 2019-03-07 | -$48.52M 10-Q · filed 2018-11-01 | -$70.86M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-06-30 | -$15.22M 10-K · filed 2019-03-07 | -$37.83M 10-Q · filed 2018-08-02 | -$60.17M derived: sum of 3 quarters · filed 2019-03-07 | -$86.03M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-03-31 | -$22.61M 10-K · filed 2019-03-07 | -$44.94M derived: sum of 2 quarters · filed 2019-03-07 | -$70.81M derived: sum of 3 quarters · filed 2019-03-07 | -$98.50M derived: sum of 4 quarters · filed 2019-03-07 |
| 2016-12-31 | -$22.33M 10-K · filed 2018-03-09 | -$48.20M derived: sum of 2 quarters · filed 2018-03-09 | -$75.89M derived: sum of 3 quarters · filed 2018-03-09 | -$103.10M 10-K · filed 2019-03-07 |
| 2016-09-30 | -$25.86M 10-K · filed 2018-03-09 | -$53.55M derived: sum of 2 quarters · filed 2018-03-09 | -$80.76M 10-Q · filed 2017-11-02 | -$105.55M derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-06-30 | -$27.69M 10-K · filed 2018-03-09 | -$54.90M 10-Q · filed 2017-08-02 | -$79.68M derived: sum of 3 quarters · filed 2018-03-09 | -$104.16M derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-03-31 | -$27.21M 10-K · filed 2018-03-09 | -$51.99M derived: sum of 2 quarters · filed 2018-03-09 | -$76.47M derived: sum of 3 quarters · filed 2018-03-09 | -$98.09M derived: sum of 4 quarters · filed 2018-03-09 |
| 2015-12-31 | -$24.78M 10-K · filed 2017-03-09 | -$49.26M derived: sum of 2 quarters · filed 2017-03-09 | -$70.88M derived: sum of 3 quarters · filed 2017-03-09 | -$85.41M 10-K · filed 2018-03-09 |
| 2015-09-30 | -$24.48M 10-K · filed 2017-03-09 | -$46.10M derived: sum of 2 quarters · filed 2017-03-09 | -$60.63M 10-Q · filed 2016-11-01 | -$75.68M derived: sum of 4 quarters · filed 2017-03-09 |
| 2015-06-30 | -$21.62M 10-K · filed 2017-03-09 | -$36.15M 10-Q · filed 2016-08-09 | -$51.20M derived: sum of 3 quarters · filed 2017-03-09 | -$56.69M derived: sum of 4 quarters · filed 2017-03-09 |
| 2015-03-31 | -$14.53M 10-K · filed 2017-03-09 | -$29.59M derived: sum of 2 quarters · filed 2017-03-09 | -$35.07M derived: sum of 3 quarters · filed 2017-03-09 | -$50.67M derived: sum of 4 quarters · filed 2017-03-09 |
| 2014-12-31 | -$15.06M 10-K · filed 2016-03-10 | -$20.54M derived: sum of 2 quarters · filed 2016-03-10 | -$36.14M derived: sum of 3 quarters · filed 2016-03-10 | -$50.01M 10-K · filed 2017-03-09 |
| 2014-09-30 | -$5.49M 10-K · filed 2016-03-10 | -$21.08M derived: sum of 2 quarters · filed 2016-03-10 | -$34.95M 10-Q · filed 2015-11-05 | -$39.30M derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-06-30 | -$15.60M 10-K · filed 2016-03-10 | -$29.47M 10-Q · filed 2015-08-10 | -$33.81M derived: sum of 3 quarters · filed 2016-03-10 | -$37.30M derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-03-31 | -$13.87M 10-K · filed 2016-03-10 | -$18.21M derived: sum of 2 quarters · filed 2016-03-10 | -$21.70M derived: sum of 3 quarters · filed 2016-03-10 | -$31.34M derived: sum of 4 quarters · filed 2016-03-10 |
| 2013-12-31 | -$4.34M 10-K · filed 2015-03-12 | -$7.83M derived: sum of 2 quarters · filed 2015-03-12 | -$17.47M derived: sum of 3 quarters · filed 2015-03-12 | -$26.07M 10-K · filed 2016-03-10 |
| 2013-09-30 | -$3.49M 10-K · filed 2015-03-12 | -$13.13M derived: sum of 2 quarters · filed 2015-03-12 | -$21.73M 10-Q · filed 2014-11-04 | -$26.02M derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-06-30 | -$9.64M 10-K · filed 2015-03-12 | -$18.24M 10-Q · filed 2014-08-07 | -$22.54M derived: sum of 3 quarters · filed 2015-03-12 | -$26.19M derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-03-31 | -$8.60M 10-K · filed 2015-03-12 | -$12.89M derived: sum of 2 quarters · filed 2015-03-12 | -$16.55M derived: sum of 3 quarters · filed 2015-03-12 | -$20.31M derived: sum of 4 quarters · filed 2015-03-12 |
| 2012-12-31 | -$4.29M 10-K · filed 2014-03-18 | -$7.95M derived: sum of 2 quarters · filed 2014-03-18 | -$11.71M derived: sum of 3 quarters · filed 2014-03-18 | -$22.23M 10-K · filed 2015-03-12 |
| 2012-09-30 | -$3.65M 10-K · filed 2014-03-18 | -$7.41M derived: sum of 2 quarters · filed 2014-03-18 | -$17.94M 10-Q · filed 2013-11-13 | |
| 2012-06-30 | -$3.76M 10-K · filed 2014-03-18 | -$14.29M 10-Q · filed 2013-09-03 | ||
| 2012-03-31 | -$10.53M 10-K · filed 2014-03-18 | |||
| 2011-12-31 | -$15.03M 10-K · filed 2014-03-18 |